Key facts
- This page summarizes Chuck Ence's Form 4 filing for RELMADA THERAPEUTICS, INC. (RLMD).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 06 Nov 2025, 07:30.
Chuck Ence - 05 Nov 2025 Form 4 Insider Report for RELMADA THERAPEUTICS, INC. (RLMD)
- Reporting relationship
- CAO and COO
- Issuer ticker
- RLMD
- Reported as of
- 05 Nov 2025
- Net transaction value
- +$299,200
- SEC form
- 4
- Accepted by SEC
- 06 Nov 2025, 07:30:05 UTC
- Prior SEC filing
- 30 Jun 2025
- Next SEC filing
- 16 Dec 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Chuck Ence
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Chuck Ence filed Form 4 for RELMADA THERAPEUTICS, INC. (RLMD) on 06 Nov 2025.
Change
- Previous filing in this sequence was filed on 30 Jun 2025.
- Current net transaction value: +$299,200.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001697779
Primary reporting owner
Ence Chuck
- Relationship
- CAO and COO
- Address
- C/O RELMADA THERAPEUTICS, INC., 2222 PONCE DE LEON BLVD, 3RD FLOOR, CORAL GABLES,
- Signature
- /s/ Chuck Ence
- Signature date
- 06 Nov 2025
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
RLMD
transaction
Common Stock
Purchase
- Transaction value
- $299,200
- Shares
- +136,000
- Change %
- +51%
- Price
- $2.20
- Shares after
- 403,931
- Date
- 05 Nov 2025
- Ownership
- Direct
* marks a reported price that did not pass the local price check.